Pharmaceutical compositions containing lipase inhibitors
US8012494B2 · kind B2 · utility
0Cited by
7References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 5, 2004 |
| Grant date | Sep 6, 2011 |
| Priority date | — |
| Expiry date | Jul 1, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/0007
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical composition comprises at least one inhibitor of lipases, preferably an inhibitor of gastrointestinal and pancreatic lipases, such as orlistat, at least one surfactant, and at least one dispersant.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.